pubmed-article:10370791 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0014644 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0205419 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C1442161 | lld:lifeskim |
pubmed-article:10370791 | lifeskim:mentions | umls-concept:C0205214 | lld:lifeskim |
pubmed-article:10370791 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10370791 | pubmed:dateCreated | 1999-8-11 | lld:pubmed |
pubmed-article:10370791 | pubmed:abstractText | In vitro studies have shown that the 30 and 69 base pair (bp) deletion variants of the latent membrane protein (LMP)-1 gene of the Epstein-Barr virus (EBV) have a higher transforming capacity than the wild-type variant. In recent years these studies have triggered an in vivo search for such potentially oncogenic variants in lymphoid tissues. | lld:pubmed |
pubmed-article:10370791 | pubmed:language | eng | lld:pubmed |
pubmed-article:10370791 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10370791 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10370791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10370791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10370791 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10370791 | pubmed:month | Apr | lld:pubmed |
pubmed-article:10370791 | pubmed:issn | 0923-7534 | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:TorelliGG | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:ArtusiTT | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:MaioranaAA | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:LuppiMM | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:MarascaRR | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:BarozziPP | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:PoggiSS | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:PileriS ASA | lld:pubmed |
pubmed-article:10370791 | pubmed:author | pubmed-author:CagossiKK | lld:pubmed |
pubmed-article:10370791 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10370791 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:10370791 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10370791 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10370791 | pubmed:pagination | 467-9 | lld:pubmed |
pubmed-article:10370791 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:meshHeading | pubmed-meshheading:10370791... | lld:pubmed |
pubmed-article:10370791 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10370791 | pubmed:articleTitle | The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign. | lld:pubmed |
pubmed-article:10370791 | pubmed:affiliation | Department of Medical Sciences, University of Modena, Italy. | lld:pubmed |
pubmed-article:10370791 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10370791 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:10370791 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10370791 | lld:pubmed |